Form 4 Tracker
Stelios Papadopoulos

Director · 2 filings · Latest: Apr 7, 2026

Ovid Therapeutics Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
EXEL
Stelios PapadopoulosNov 12, 2025
Proposed Sale
$43.55100,000$4.4M
EXEL
STELIOS PAPADOPOULOSMay 15, 2025
Proposed Sale
$44.3536,508$1.6M